Abatacept as maintenance therapy in kidney transplantation: a retrospective comparative study

Charlotte Uro-Coste, Inès Ramos, Aurélien Tiple, Marine Freist, Claire Chatron, Alba Atenza, Jimmy Garraud, Clarisse Grèze, Carole Philipponnet, Paul Rouzaire, Anne-elisabeth Heng, Cyril Garrouste · 2026

Read Abatacept as maintenance therapy in kidney transplantation: a retrospective comparative study by Charlotte Uro-Coste, Inès Ramos, Aurélien Tiple, Marine Freist, Claire Chatron, Alba Atenza, Jimmy Garraud, Clarisse Grèze, Carole Philipponnet, Paul Rouzaire, Anne-elisabeth Heng, Cyril Garrouste (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616798.txt.

Description

Charlotte Uro-Coste and co-authors compare two related immune drugs as upkeep therapy after kidney transplant. Their 2026 study reviews patients switched to one drug or the other from 2017 to 2023. The better-known drug is given by vein and faces supply gaps, which spurs interest in its cousin.

Seventy-four patients took part, split unevenly between the two drugs. Rejection within a year of the switch hit about one patient in ten in both groups. Rates of viral and opportunistic infections also matched. The authors judge the lesser-used drug acceptably safe by comparison. They suggest it as a backup when supply fails, vein access is poor, or more patient autonomy is sought, pending larger trials.

Catalog record

CREATORCharlotte Uro-Coste, Inès Ramos, Aurélien Tiple, Marine Freist, Claire Chatron, Alba Atenza, Jimmy Garraud, Clarisse Grèze, Carole Philipponnet, Paul Rouzaire, Anne-elisabeth Heng, Cyril Garrouste
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13616798

Browse the full library · About the Tower of Babel